Activin Receptor 1 Market Overview
The Activin Receptor 1 Market was valued at USD 800 million in 2024 and is projected to reach USD 1,500 million by 2035, growing at a CAGR of 5.9%. Activin Receptor 1 (ACVR1) is a critical signaling protein involved in tissue development, bone formation, and cellular growth regulation. Its therapeutic relevance spans oncology, cardiovascular diseases, bone disorders, and neurological...
0 Commentaires 0 Parts 52 Vue 0 Aperçu